Each year, millions of people live with chronic hepatitis B that slowly develops into cirrhosis. Once cirrhosis patients suffer decompensation issues including fluid buildup in the belly and dangerous esophageal bleeding, their risks of repeated hospital stays and early death rise sharply.
Clinicians mostly judge liver risk through one-time liver blood tests, which miss gradual whole-body tissue changes that drive disease deterioration. In a study published in Hepatobiliary Communications , researchers from The First Hospital of Lanzhou University uncovered clear, stage-specific tissue patterns from standard CT scans to predict upcoming severe liver complications.
“We found that visceral fat and muscle shifts carry totally different warning meaning based on how advanced a patient’s cirrhosis is,” shares co-lead author Xiaoyue Zhang. “For patients with compensated early-stage cirrhosis, gradual degeneration of visceral fat signals a significantly higher risk of complications, and for those who have already experienced severe hepatic decompensation events, persistent muscle wasting serves as the primary warning marker.”
The researchers confirmed tracking long-term tissue shifts delivers much more accurate risk alerts than isolated examinations. “Above all, these fat and muscle changes can be spotted on routine abdominal CT scans that every cirrhosis patient already undergoes, with no extra expensive or invasive testing needed,” adds Zhang.
According to senior and corresponding author Junfeng Li, the team's findings addressed an unmet clinical demand in daily liver disease management. “Past research rarely split cirrhosis patients by disease stage to sort out these tissue warning signals,” explains Li. “This easy CT monitoring method allows clinicians to launch personalized nutritional and metabolic support early, effectively slowing liver damage and lifting long-term survival chances for hepatitis B cirrhosis patients.”
###
Contact the author: Junfeng Li, Department of Liver Disease, The First Hospital of Lanzhou University, No.1 Donggang West Road, Chengguan District, Lanzhou 730000, China. junfenglee@126.com
The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).
Observational study
People
Dynamic Changes in Visceral Fat Density and Skeletal Muscle Index Predict New-onset Decompensation in Chronic Hepatitis B-Related Cirrhosis
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.